Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
562-02-006 ISMRM Abstract

Integrating DCE-MRI Multiparametric Maps and Digital Pathological Images to Predict Pathological Response in Breast Cancer

Primary: Body - Breast
Secondary: Analysis Methods - Radiomics
562-02-006 · Breast MRI and the Role of AI · Wednesday, 13 May, 9:15 AM–10:10 AM · Digital Posters Row C
Keywords: Breast cancer DCE-MRI Neoadjuvant Chemotherapy Quantitative parameters Digital Pathology
Accepted
Huidong Wang 1, Siyao Du2, Ruimeng Zhao2, LINA ZHANG1
1Department of Radiology, the Fourth Affiliated Hospital of China Medical University, Shenyang, China
2Department of Radiology, Department of radiology, The First Hospital of China Medical University, Shenyang, China
Presenting Author: Huidong Wang

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Mao N, Dai Y, Zhou H, Lin F, Zheng T, Li Z, Yang P, Zhao F, Li Q, Wang W, Liang Y, Xie H, Ma H, Zhang L, Guo Y, Song X, Zhang H, Lu J. A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer. Sci Adv. 2025 May 2;11(18):eadr1576. doi: 10.1126/sciadv.adr1576. Epub 2025 Apr 30. [doi]
2. Ramtohul T, Lepagney V, Bonneau C, Jin M, Menet E, Sauge J, Laas E, Romano E, Bello-Roufai D, Mechta-Grigoriou F, Vincent Salomon A, Bidard FC, Langer A, et al. Use of Pretreatment Perfusion MRI-based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy. Radiology. 2024 Sep;312(3):e240575. doi: 10.1148/radiol.240575. [doi]
3. Wu C, Wang L, Wang N, et al. Prediction of Early Neoadjuvant Chemotherapy Response of Breast Cancer through Deep Learning-based Pharmacokinetic Quantification of DCE MRI. Radiol Artif Intell. 2025;7(5):e240769. doi:10.1148/ryai.240769. [doi]
4. Lin H, Hua J, Gong Z, et al. Multimodal radiopathological integration for prognosis and prediction of adjuvant chemotherapy benefit in resectable lung adenocarcinoma: A multicentre study. Cancer Lett. 2025;616:217557. doi:10.1016/j.canlet.2025.217557. [doi]
5. Zhang X, Teng X, Zhang J, et al. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity. Breast Cancer Res. 2024;26(1):77. Published 2024 May 14. doi:10.1186/s13058-024-01836-3. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/562-02-006